Summary of Purpose
This is a multicenter, randomized, double-blind, placebo-controlled trial aims to assess the effectiveness of rTMS in treating depression after basal ganglia ischemic stroke and to examine whether such effects are related to restoration of white matter integrity.Sixty-six participants will be recruited from three centers and randomized with a 1:1 ratio to receive active rTMS treatment or sham rTMS treatment in...Read More →
The following dates are available for this trial. Trial information last updated on 16 May 2017.
|1 Jun 2017||1 May 2017||31 May 2020||31 May 2020||1 Jan 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Zhujiang Hospital Lead
- Lianxu Zhao, M.D